|
CACR |
Interim Financial Statements for the period ended September 30, 2023 |
Interim Financial Statements |
29/11/2023 |
 Open Filing (523.56 KB) |
|
CACR.A |
Interim Financial Statements for the period ended September 30, 2023 |
Interim Financial Statements |
29/11/2023 |
Open Filing (523.56 KB) |
|
AOC |
AOC - CSE form 5 - Q3 2023 |
Quarterly Listing Statement |
29/11/2023 |
Open Filing (535.99 KB) |
|
MBAI |
News Release - Company Announces the Release of New Investment Presentation - MedMatrix |
Press Release |
29/11/2023 |
Open Filing (170.48 KB) |
|
PNGC |
Form 5 - 2023 Q3 |
Quarterly Listing Statement |
29/11/2023 |
Open Filing (412.77 KB) |
|
EVM |
Interim MD&A - Q3 September 30, 2023 |
MD&A (Management Discussion and Analysis) |
29/11/2023 |
Open Filing (674.15 KB) |
|
EVM |
Interim Financial Statements - Q3 September 30, 2023 |
Interim Financial Statements |
29/11/2023 |
Open Filing (401.63 KB) |
|
GFCO |
Quarterly Listing Statement |
Quarterly Listing Statement |
29/11/2023 |
Open Filing (1.14 MB) |
|
WOGC |
Q3 MD&A |
MD&A (Management Discussion and Analysis) |
29/11/2023 |
Open Filing (308.47 KB) |
|
WOGC |
Q3 Financial Statements |
Interim Financial Statements |
29/11/2023 |
Open Filing (253.94 KB) |
